Dr. Kevin Cheung is a current postdoctoral fellow in the lab of Professor Hongkun Park in the Department of Chemistry and Chemical Biology at Harvard University. There, his research involves investigating nano-bio interfaces, particularly neuroelectronic interfacing with CMOS nanoelectrode arrays.
Kevin received a B.S. in chemistry, with honors, from the University of California, Santa Barbara (UCSB) in 2014. At UCSB, he performed research in the lab of Professor Norbert Reich on the spatiotemporal release of siRNA from Au nanoshells via pulsed near-infrared laser irradiation for targeted gene knockdown in cancer and stem cells. In 2013, he was one of three US students chosen through the Cooperative International Science and Engineering Internships program for a research internship at the Department of Materials at the University of Oxford. There, he performed research in the lab of Professor Kyriakos Porfyrakis on the synthesis and purification of endohedral metallofullerenes for applications in quantum computing.
He then received a Ph.D. in chemistry, with a specialization in materials and nanoscience, from the University of California, Los Angeles (UCLA) in 2019, under the mentorship of Professor Anne Andrews and Professor Paul Weiss. His Ph.D. research focused on the design and development of next-generation electronic biosensors using artificial nucleic acid receptors (aptamers) for point-of-care and personalized healthcare applications, as well as measuring neurotransmission in vivo. He also advanced novel soft-lithographic surface patterning techniques.
Additionally, Kevin is a member of the American Chemical Society and the International Society on Aptamers, and serves as a member of the Communications Committee for the ACS Division of Analytical Chemistry.